Clinical Trial Update: Patient Registry of Roflumilast In Real Life

View source ↗

Summary

A real-world patient registry study assessing roflumilast in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED